Homologous Recombination Deficiency Score Shows Superior Association With Outcome Compared With Its Individual Score Components in Platinum-Treated Serous Ovarian Cancer

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2016.04.034
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Characterisation of Homologous Recombination Deficiency in Paired Primary and Recurrent High-Grade Serous Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Age-Adjusted Association of Homologous Recombination Genes With Ovarian Cancer Using Clinical Exomes as Controls

Hereditary Cancer in Clinical Practice
OncologyGenetics
2019English

PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Current Gleason Score 3 + 4 = 7: Has It Lost Its Significance Compared With Its Historical Counterpart?

BJU International
Urology
2016English

OC08.07: Ultrasound-Based Score for Predicting Debulking Surgery Outcome in IIB-IV Stage Epithelial Ovarian Cancer

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

Early Prognostic Score for Neurological Outcome at 6 Months After Cardiac Arrest Treated With Hypothermia

Intensive Care Medicine Experimental
Critical CareIntensive Care Medicine
2015English

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab

Clinical Medicine Insights: Oncology
Oncology
2019English

LabBM Score and Extracranial Score as New Tools for Predicting Survival in Patients With Brain Metastases Treated With Focal Radiotherapy

Cureus
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy